Contribute Try STAT+ Today

Editor’s note: A recording of the event is embedded above. A version of this recording with closed captioning can be found on our YouTube page here

Europe’s largest cancer research meeting, the ESMO Virtual Congress, recently took place on Sept. 19-21. With the event behind us, STAT’s Adam Feuerstein will moderate a panel with some top cancer experts to review the significant data presented at ESMO, discuss what to expect for the rest of the year in cancer clinical trials, and take your questions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.